Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma

BACKGROUND & AIMS: In approximately 70% of patients with hepatocellular carcinoma (HCC) treated by resection or ablation, disease recurs within 5 years. Although gene expression signatures have been associated with outcome, there is no method to predict recurrence based on combined clinical, pat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Villanueva, Augusto, Hoshida, Yujin, Battiston, Carlo, Tovar, Victoria, Sia, Daniela, Alsinet, Clara, Cornella, Helena, Liberzon, Arthur, Kobayashi, Masahiro, Kumada, Hiromitsu, Thung, Swan N., Bruix, Jordi, Newell, Philippa, April, Craig, Fan, Jian-Bing, Roayaie, Sasan, Mazzaferro, Vincenzo, Schwartz, Myron E., Llovet, Josep M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3081971/
https://ncbi.nlm.nih.gov/pubmed/21320499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2011.02.006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia